Skip to main content
SpringerLink
Log in

COBAS® AmpliPrep/COBAS® TaqMan® HCV Test

  • Chapter
  • First Online:
Modern Clinical Molecular Techniques

  • 1894 Accesses

Abstract

The Roche COBAS AmpliPrep/COBAS TaqMan HCV Test utilizes real-time PCR technology and involves automated specimen preparation followed by automated reverse transcription, PCR amplification, and detection of HCV target RNA from peripheral blood specimens. The dynamic range of the assay is 43 IU/mL to 69,000,000 IU/mL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. COBAS® AmpliPrep/COBAS® TaqMan® HCV Test package insert, Roche Molecular Systems, Inc., Document Revision 4.0. www.accessdata.fda.gov/cdrh_docs/pdf6/P060030c.pdf

    Article  CAS  Google Scholar 

  2. World Health Organization Available at: http://www.int/vaccine_research/diseases/viral_cancers/en/index2.htmlAccessed 17 Feb 2012.

    Google Scholar 

  3. Armstrong GI, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–14.

    Article  PubMed  CAS  Google Scholar 

  4. Verna EC, Brown Jr RS. Hepatitis C virus and liver transplantation. Clin Liver Dis. 2006;10:919–40.

    Article  PubMed  CAS  Google Scholar 

  5. Jaeckel E, Cornberg M, Sedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001;345:1452–7.

    Article  PubMed  CAS  Google Scholar 

  6. Watanabe H, Saito T, Shinzawa H, Okumoto K, Hattori E, Adachi T, Takeda T, Sugahara K, Ito J, Saito K, Togashi H, Suzuki R, Hayashi M, Miyamura T, Matsuura Y, Kawata S. Spontaneous elimination of serum hepatitis C virus RNA in chronic HCV carriers: a population-based cohort study. J Med Virol. 2003;71:56–61.56–61.

    Article  PubMed  CAS  Google Scholar 

  7. Zeuzem S, Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?. Ann Intern Med. 2004;140:370–81.

    PubMed  Google Scholar 

  8. Fung J, Lai CL, Hung I, Young J, Cheng C, Wong D, Yuen M-F. Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. J Infect Dis. 2008;198:808–12.

    Article  PubMed  Google Scholar 

  9. Yu ML, Dai CY, Huang JF, Hou NJ, Lee LP, Hsieh M-Y, Chiu C-F, Lin Z-Y, Chen S-C, Hsieh M-Y, Wang L-Y, Chang W-Y, Chuang W-L. A randomized study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis. Gut. 2007;56:553–9.

    Article  PubMed  CAS  Google Scholar 

  10. Shiffman ML, Suter F, Bacon BR, Nelson D, Harley H, Sola R, Shafran SD, Barange K, Lin A, Soman A, Zeuzem S. Peg-interferon alpha-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. N Engl J Med. 2007;357:124–34.

    Article  PubMed  Google Scholar 

  11. Lagging M, Langeland N, Pedersen C, Farkkila M, Buhl MR, Morch K, Dhillon AP, Alsio A, Hellstrand K, Westin J, Christensen P, Leutscher P, Norkrans G for the NORDynamIC Study Group. Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection. Hepatology. 2008;48:695.

    Article  PubMed  Google Scholar 

  12. Poordad F, McCone Jr J, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki J-P. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med. 2011;364:1195–206.

    Google Scholar 

  13. Bacon B, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med. 2011;364:1207–17.

    Google Scholar 

Download references

Acknowledgment

Roche Molecular Diagnostics has granted permission to use a portion of the COBAS® AmpliPrep/COBAS® TaqMan® Test, Document Revision 4.0 package insert, in this chapter.

Author information

Authors and Affiliations

  1. Department of Pathology, Ben Taub General Hospital and Baylor College of Medicine, 1504 Taub Loop, Houston, TX, 77030, USA

    Charles E. Stager Ph.D., D(ABMM)

  2. Molecular Laboratory, Ben Taub General Hospital, Houston, TX, USA

    Tavat A. Buraruk BS, MT(ASCP)

Authors
  1. Charles E. Stager Ph.D., D(ABMM)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tavat A. Buraruk BS, MT(ASCP)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles E. Stager Ph.D., D(ABMM) .

Editor information

Editors and Affiliations

  1. , Molecular Genetic Technology Program, M.D. Anderson Cancer Center, 1515 Holcombe Blvd. Unit 2, Houston, 77030, Texas, USA

    Peter Hu

  2. , Department of Human Genetics, Emory University School of Medicine, 615 Michael St. NE, Suite 315, Atlanta, 30322, Georgia, USA

    Madhuri Hegde

  3. , Molecular Genetic Technology Program, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 2, Houston, 77030, Texas, USA

    Patrick Alan Lennon

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Stager, C.E., Buraruk, T.A. (2012). COBAS® AmpliPrep/COBAS® TaqMan® HCV Test. In: Hu, P., Hegde, M., Lennon, P. (eds) Modern Clinical Molecular Techniques. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2170-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-2170-2_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-2169-6

  • Online ISBN: 978-1-4614-2170-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation